Growing Demand for Inexpensive, Effective Drugs and Continuing Patent Expiries Provide Growth Prospects for the European Generics Market.(Industry overview)

PR Newswire Europe, July, 2007

LONDON, July 12 /PRNewswire/ -- With an ageing population and expensive drugs driving healthcare costs upwards, generic medicines are gaining significance in Europe. The governments are under tremendous pressure to reduce healthcare expenditure. In this scenario, generics are widely regarded as the best method to allow access to safe, effective and high quality drugs at affordable prices to a vast majority of patients.

New analysis from Frost & Sullivan (rmtheodore@frost.com with your full name, company name, title, telephone number, e-mail address, city, state and country. We will send you the information through e-mail upon receipt of the above information.

Premium Content Partnership | HighBeam Research provides an in-depth online archive library of reference works. HighBeam Research

 

BNET TalkbackShare your ideas and expertise on this topic

Please add your comment:

  1. You are currently: a Guest |
  2.  

Basic HTML tags that work in comments are: bold (<b></b>), italic (<i></i>), underline (<u></u>), and hyperlink (<a href></a)

advertisement
advertisement
  • Click Here
  • Click Here
  • Click Here
advertisement